Equillium to present at the jefferies global healthcare conference

La jolla, calif.--(business wire)---- $eq--equillium, inc. (nasdaq: eq), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that it will present at the jefferies global healthcare conference taking place at the marriott marquis in new york, ny, june 4 – 6, 2024. management will provide an overview of the company's clinical programs – including eq101 for the treatment for alopecia areata with data expecte.
EQ Ratings Summary
EQ Quant Ranking